Skip to content
MARKETS / NASDAQ / STLN
NASDAQ · SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE · MID CAP

Starling Oncology, Inc. STLN

6 fiscal years on record · USD · FY2025 reported · SEC filings only
$502.7M
▲ 27.8% YoY
$-60.6M
$-27.8M
Growth
USD 502.7M
Revenue, FY2025 · full 6-year series below
Revenue $M Net income $M
FY2025 · Revenue 502.7 · Net income -60.6
200M400M-40M-80M202020212022202320242025
Compound annual growth
+25.8%
+21.8%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +21.8% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−12 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -7.2% · Net -12.1%
-10%-20%-30%202020212022202320242025
ROE
FY2024 · ROE -213.4%
-100%-200%202020212022202320242025

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -27.8
-25.0M-50.0M202020212022202320242025
Net buybacks $M Dividends $M
FY2024 · Dividends — · Net buybacks 0.0
4M8M2021202220232024

Total assetsUSD 164.7M
EquityUSD -15.7M
CashUSD 33.6M
Gross debtUSD 77.4M
Net debtUSD 43.8M
Current ratio1.59×

Equity was negative — liabilities exceeded assets. No ratio is shown.

The 6-year record
6 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 202520242023202220212020
Revenue $B0.50.40.30.30.20.2
Operating income $B−0.0−0.1−0.1−0.1−0.0−0.0
EBITDA $B−0.0−0.1−0.1−0.1−0.0−0.0
Income tax $B−0.00.0−0.0−0.0−0.0−0.0
Net income $B−0.1−0.1−0.10.0−0.0−0.0
Free cash flow $B−0.0−0.0−0.0−0.1−0.0−0.0
EPS, diluted $−0.54−0.71−0.92−0.21−0.16−0.24
Dividend / sh $······
Payout %······
ROE %·−213.4−92.20.1−16.5−40.7
Shares out B0.100.080.070.070.070.01

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 1 failures in 27 reconciliationsAUDITED

Reconciled in 6 of 19 fiscal years. 49 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente1 failures
ActivityServices-Offices & Clinics of Doctors of Medicine
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2019

Share this section

Download image